AGER and prostate cancer: We found that in prostate cancer patients with the RAGE SNPs rs2070600 ‘GA’ genotype were associated with lower risk to develop grade group upgrade (AOR = 0.628, 95% CI = 0.426–0.976; p = 0.019) (Table 2).